phosphoramide has been researched along with Cystic Fibrosis in 1 studies
*Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berchel, M; Gill, D; Hyde, S; Jaffrès, PA; Laurent, V; Le Gall, T; Montier, T; Mottais, A; Sibiril, Y | 1 |
1 other study(ies) available for phosphoramide and Cystic Fibrosis
| Article | Year |
|---|---|
Antibacterial effect and DNA delivery using a combination of an arsonium-containing lipophosphoramide with an N-heterocyclic carbene-silver complex - Potential benefits for cystic fibrosis lung gene therapy.
Topics: Anti-Bacterial Agents; Cell Line; Cystic Fibrosis; DNA; Drug Carriers; Gene Transfer Techniques; Genetic Therapy; Gram-Positive Bacteria; Humans; Lung; Methane; Microbial Sensitivity Tests; Nanoparticles; Phosphoramides; Pseudomonas aeruginosa; Silver | 2018 |